Group 1 - The core point of the article is the strategic cooperation between Hanyu Pharmaceutical and the digital asset platform KuCoin to explore the tokenization of "future revenue rights of innovative drug research and development" as a pilot project in Hong Kong [1] - The company is actively exploring innovative models based on its operational needs and appreciates suggestions regarding potential collaborations with major shareholders and other digital asset platforms [1]

根据协议，翰宇药业将以其在GLP-1类多肽重磅药物领域的技术积累与研发管线为基础资产，KuCoin则 将发挥其在区块链技术、RWA全流程解决方案和全球合规资源方面的优势，为该项目提供链上映射、 资产通证化、交易撮合、收益分配等一体化支持。 人民财讯8月4日电，据翰宇药业（300199）消息，8月4日，翰宇药业与数字资产平台KuCoin正式签署 战略合作意向书，双方拟共同探索在香港共同推进中国内地首个以"创新药研发未来收益权"为底层资产 的RWA(Real World Asset)代币化试点项目。 ...